Phaco Training: Ziv-aflibercept correlated with BCVA, CMT improvements Bonyadi MHJ, et al. Ophthalmic Surg Lasers Imaging Retina. 2019;doi:10.3928/23258160-20191031-03.
Visual acuity improved beyond that expected in relation to reduction in central macular thickness when a 2.5 mg dose of intravitreal ziv-aflibercept was used in patients with diabetic macular edema, according to a study. CMT and BCVA were evaluated over the course of 1 year of treatment with 2.5 mg or 1.25 mg of intravitreal ziv-aflibercept (IVZ; Zaltrap,… Read More »